共 50 条
Enhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate
被引:136
|作者:
Pujara, Naisarg
[1
,2
]
Jambhrunkar, Siddharth
[1
,2
]
Wong, Kuan Yau
[2
]
McGuckin, Michael
[2
]
Popat, Amirali
[1
,2
]
机构:
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Translat Research Inst, Inflammatory Dis Biol & Therapeut Grp, Mater Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia
基金:
英国医学研究理事会;
关键词:
Resveratrol;
Soy protein isolate;
Nanocomplex;
Colloidal stability;
Solubility;
Control release;
SILICA NANOPARTICLES ENHANCE;
TRANS-RESVERATROL;
CANCER-TREATMENT;
CIS-RESVERATROL;
BIOAVAILABILITY;
CYTOTOXICITY;
CURCUMIN;
DELIVERY;
STABILIZATION;
ABSORPTION;
D O I:
10.1016/j.jcis.2016.11.015
中图分类号:
O64 [物理化学(理论化学)、化学物理学];
学科分类号:
070304 ;
081704 ;
摘要:
The polyphenolic compound resveratrol has received significant attention due to its many pharmacological actions such as anti-cancer, anti-inflammatory, antioxidant and antimicrobial activities. However, poor solubility and stability are major impediments for resveratrol's clinical effectiveness. In this work we have encapsulated resveratrol into soy protein isolate nanoparticles using a simple rotary evaporation technique. Resveratrol-loaded nanoparticles were around 100 nm in diameter and negatively charged. Nano-encapsulated resveratrol was found to be in amorphous form and showed more than two times higher solubility with significantly increased dissolution when compared to free resveratrol. Finally, an in-vitro NF-kappa B inhibition assay revealed that encapsulated resveratrol was stable and retained bioactivity. This new formulation of resveratrol has the potential to boost the clinical effectiveness of this drug and could be utilised for other poorly soluble hydrophobic drugs. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:303 / 308
页数:6
相关论文